×
The Standard e-Paper
Join Thousands of Readers
In 2016, Kenya was hailed as a global pioneer for rolling out daily Oral PrEP.
Lenacapavir, recently introduced in Kenya, is a long-acting HIV preventive medicine, not a vaccine, offering six-monthly protection through pre-exposure prophylaxis (PrEP).
Subscribe to our newsletter and stay updated on the latest developments and special offers!
Join